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1. Introduction
   Syphilis, caused by Treponema pallidum is a classical 
example of a sexually transmitted disease (STD) that can be 
successfully controlled by effective public health measures due 
to the availability of a sound diagnostic test and effective and 
economical treatment options. The World Health Organization 
estimates that 10-12 million new infections of syphilis occur every 
year[1]. Infection rates show extreme variation between countries 
of the same region as well as various subcategories of populations 
studied[2-5]. Indian data on syphilis seroprevalence is meagre, 
with incidence rates ranging from 5.4 per 100 persons each year 
in a sexually transmitted infection clinic to prevalence of 21.9% 
in convenience samples of long distance truck drivers[6-8]. The 
present study was aimed at understanding the occurrence of 
syphilis among various patient groups attending a tertiary care 
hospital and studying the trends over a period of three years.
2. Materials and methods
   The study was conducted in a tertiary care teaching hospital 
in Southern India from January 2006 till December 2008. A 
retrospective analysis of laboratory log book maintained for 
syphilis tests was performed for this period. A total of 14 639 
samples were received from various patient groups including 
antenatal cases, patients attending STD clinic, blood donors and 
HIV positive patients.
   Screening for syphilis was performed by venereal disease 
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reasearch laboratory (VDRL) test. Serum samples from all patients 
were tested by qualitative VDRL using standard procedures. 
Samples positive for VDRL were subjected to a quantitative VDRL 
test using serum dilutions from 1 in 2 upto 1 in 64. A specific 
treponemal test, Treponema pallidum hemagglutination assay 
(TPHA) was peformed on samples positive in the quantitative 
VDRL. Samples positive in both tests were designated as 
seropositive for syphilis.
   Statistical analysis of data was done by using SPSS version 16. 
Results were summarized using descriptive statistics. Pearson’s 
Chi-square test was used to evaluate differences between 
proportions. Chi-square for linear trends was calculated.
   The study was approved by institute ethics committee.Patient 
information obtained during the study was kept confidential. 
3. Results
   Among the 14 639 samples collected, 103 were positive by 
VDRL test. Of these 89 were positive by quantitative VDRL and 
TPHA. The year wise distribution of these cases is shown in Table 
1. The cumulative seroprevalence over three years was found to 
be 0.61% in this study. The syphilis seroprevalence reduced from 
0.88% in 2006 to 0.40% in 2008, which was statistically significant 
(χ2=9.16, P=0.010 3).
Table 1
Seroprevalence of syphilis infection from the study period January 2006 till 
December 2008.
Year No. tested No. positive by VDRL 
[n (%)] 
No. positive by TPHA
[n (%)]
2008  5 188  24 (0.46) 21 (0.40)
2007  4 897  31 (0.63) 28 (0.57)
2006  4 554  48 (1.05) 40 (0.88)
Total 14 639 103 (0.70) 89 (0.61)
   Among the various sub-populations study, patients attending 
the sexually transmitted infection clinic showed a seroprevalence 
of 2.62% (Table 2). The seroprevalence decreased significantly 
from 4% in 2006 to 1.39% in 2008 (χ2=12.543 3, P=0.001 9). 
The antenatal group showed a seroprevalence of 0.12% (χ2=1.07, 
P=0.58) whereas congenital syphilis was seen in 0.61% of pediatric 
age group tested. Among the HIV positive individuals screened for 
syphilis, 6.5% were positive for treponemal antibodies (Table 3). 
None of the blood donors were positive for syphilis. Miscellaneous 
groups of patients admitted to other broad specialities with features 
suggestive of secondary or tertiary syphilis were also screened. The 
seropositivity in this group was 2.11%.
Table 2
Seroprevalence of syphilis among patients attending STD clinic, antenatal 
screening and pediatric age group.
Year STD clinic Antenatal screening Paediatric group
Tested Positive [n(%)] Tested Positive [n(%)] Tested Positive [n(%)]
2008 1 009 14 (1.39) 1912 3 (0.16) 157 1 (0.64)
2007   902 24 (2.66) 1879 3 (0.16) 213 1 (0.46)
2006   875 35 (4.00) 1834 1 (0.05) 124 1 (0.81)
Total 2 786 73 (2.62) 5625 7 (0.12) 494 3 (0.61)
Table 3
Seroprevalence of syphilis among HIV patients screened, blood donors and 
other patients screened for syphilis.
Year HIV patients Blood donors Others
Tested Positive [n(%)] Tested Positive [n(%)] Tested Positive [n(%)]
2008  60 4 (6.67) 1 967 0 (0)  83 2 (2.41)
2007  53 2 (3.77) 1 763 0 (0)  87 1 (1.15)
2006  24   3 (12.50) 1 677 0 (0)  20 1 (4.00)
Total 137       9 (6.57) 5 407 0 (0) 190 4 (2.11)
4. Discussion
   
   The present study was determined the seroprevalence of 
syphilis in patients attending a tertiary care centre and studied 
short term trends in changing rates of syphilis in various 
subgroups of patients. Various studies from India have shown 
varied rates of syphilis depending upon the population study. 
Studies from STD clinics have shown seroprevalence ranging 
from 5.4% to 8.2%[8,9]. Our study showed a statistically 
significant declining rate of syphilis in STD clinics as well as 
the overall seroprevalence. These findings could be interpreted 
as indicators of improved programmes for prevention and 
management of STDs as well as availability of treatment in 
STD clinics[9].
   Indian studies on syphilis from antenatal groups has shown a 
seroprevalence of 0.84% to 0.98%[10,11]. Low seroprevalence of 
0.12% was also seen in the current study. However, as syphilis 
can cause adverse outcomes of pregnancy in 80% of the cases, 
including stillbirths, abortions, perinatal death and neonatal 
infections in a significant number of cases, the importance 
of screening antenatal women for syphilis should always be 
highlighted[12].
   Co-infection rates of syphilis and HIV have been showing 
a worrisome trend in several countries, with urban outbreaks 
in men who have sex with men showing rates of 20%-
73%[13]. In India, variable syphilis-HIV coinfection rates 
have been described[14]. Eventhough our study shows that 
6.5% of diagnosed HIV patients were positive for syphilis, 
the results have to be interpreted with caution. The HIV 
positive individuals included in our study were symptomatic 
individuals who had presented to clinic for antiretroviral 
treatment. Therefore, all HIV positive individuals were not 
screened in the study unlike other studies which have screened 
large HIV positive cohorts. Syphilis and HIV co-infection 
presents a complex interaction. The increased incidence of 
HIV in homosexual and heterosexual individuals afflicted with 
STD, including syphilis is epidemiologically documented in 
numerous studies[15,16]. HIV alters the course of syphilis as 
well as the response to treatment. Incidence of neurosyphilis 
in HIV infected individuals is high even when treated with 
recommended dosage[17]. Altered serological responses in HIV 
positive patients also underlines the need for treponemal tests 
in this patient group. The need for further studies in this area 
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should be overemphasized.
   Our study had several limitations. Its retrospective nature 
limited evaluation of several parameters like risk evaluation of 
particular groups such as men who have sex with men, rural 
and urban population, etc. Secondly, it was a hospital based 
study and population-based community studies are likely to 
show different results. Finally, the study looked into short term 
trends ranging over a period of 3 years. Long term evaluation of 
these trends will undoubtedly yield more epidemiological data. 
Nevertheless, findings of this study can help us understand the 
disease trends at a larger scale.
   Eventhough the prevalence of syphilis is on the decline, 
screen of high risk populations should be continued to avoid 
the complications of undiagnosed and untreated syphilis.
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